1 / 44

Clinical Evaluation of Glomerular Filtration

Clinical Evaluation of Glomerular Filtration. S.P. DiBartola, DVM D.J. Chew, DVM. The ideal substance to measure GFR would …. Be freely filtered at the glomeruli Not be bound to plasma proteins Not be metabolized Be non-toxic Be excreted only by the kidneys

erik
Download Presentation

Clinical Evaluation of Glomerular Filtration

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Clinical Evaluation of Glomerular Filtration S.P. DiBartola, DVM D.J. Chew, DVM

  2. The ideal substance to measure GFR would … • Be freely filtered at the glomeruli • Not be bound to plasma proteins • Not be metabolized • Be non-toxic • Be excreted only by the kidneys • Be neither reabsorbed nor secreted by the renal tubules • Be stable in blood and urine • Be easily measured

  3. Clinical Assessment of GFR • BUN • Serum creatinine • Creatinine clearance (endogenous or exogenous) • Sodium sulfanilate • Radioisotopes

  4. Essential terminology • Renal disease • Renal failure • Azotemia • Uremia

  5. Renal disease • Implies the presence of histologic lesions in the kidney but does not specify any degree of renal dysfunction

  6. Renal failure • Implies that 75% of the total nephron population has become non-functional but does not necessarily imply underlying histologic lesions

  7. Azotemia • Increased concentration of non-protein nitrogenous waste products (e.g. urea, creatinine) in the blood

  8. Azotemia • Pre-renal: due to reduced renal perfusion • Renal: due to renal parenchymal disease • Post-renal: due to impaired elimination of urine from the body

  9. Uremia • The constellation of clinical and biochemical abnormalities associated with a critical loss of functioning nephrons • Includes the extra-renal manifesations of renal failure

  10. Blood urea nitrogen (BUN) • Dogs: 8-25 mg/dL • Cats: 15-35 mg/dL • Horses: 10-27 mg/dL • Cattle: 5-23 mg/dL Normal values may vary among laboratories

  11. Production of urea • Synthesized in liver using NH3 derived from amino acids of endogenous (body) or exogenous (dietary) proteins • Not produced at a constant rate (affected by protein intake) NH4+ + CO2 + 3ATP + 2H2O + aspartate  urea + 2ADP + 2Pi + AMP + PPi + fumarate + 2H+

  12. Distribution and excretion of urea • Freely permeable and distributed throughout total body water • Renal excretion most important • Filtered by glomeruli • Passively reabsorbed in renal tubules depending on tubular flow rate • Not secreted by renal tubules • Not excreted at a constant rate (high protein meal transiently increases GFR)

  13. Measurement of urea • Technically easy and reproducible • Measured by diacetylmonoxamine or urease methodology • Urease methodology most specific and accurate (used on Hitachi autoanalyzer) • Dipstrip (e.g. Azostix) methods not very accurate

  14. Abnormal BUN concentration • Non-renal factors • Renal factors • Pre-renal (e.g. dehydration, heart failure, shock) • Renal (e.g. parenchymal renal disease) • Post-renal (e.g. urethral obstruction, ruptured bladder)

  15. Abnormal BUN: Non-renal factors • Increased BUN • High protein meal • Hemorrhage into gastrointestinal tract • Increased catabolism • Drugs (glucocorticoids, azathioprine, tetracycline) • Decreased BUN • Low protein diet • Severe liver disease or portosystemic shunt • Drugs (anabolic steroids)

  16. Creatinine • Dogs: 0.3-1.2 mg/dL • Cats: 0.8-1.8 mg/dL • Horses: 1.0-1.8 mg/dL • Cattle: 0.6-1.5 mg/dL Normal values may vary among laboratories

  17. Production of creatinine • Non-enzymatic breakdown product of phosphocreatine in muscle • Produced at a relatively constant rate based on age, gender, and muscle mass • Not affected by diet

  18. Distribution and excretion of creatinine • Freely permeable and distributed throughout total body water • Renal excretion most important • Filtered by glomeruli • Not reabsorbed by renal tubules • Not secreted by renal tubules • Excreted at a relatively constant rate

  19. Measurement of creatinine • Usually measured by alkaline picrate method (used on Hitachi autoanalyzer) • Measures creatinine and non-creatinine chromagens

  20. Measurement of creatinine: Non-creatinine chromagens • May constitute up to 50% of measured “creatinine” at normal serum creatinine concentrations (but progressively less as renal function declines) • Do not appear in urine (affects clearance calculations) • Special techniques to circumvent them are not in common use by clinical laboratories

  21. Abnormal serum creatinine concentration • Non-renal factors (usually transient) • Renal factors • Pre-renal (e.g. dehydration, heart failure, shock) • Renal (e.g. parenchymal renal disease) • Post-renal (e.g. urethral obstruction, ruptured bladder)

  22. Abnormal serum creatinine concentration: Non-renal factors • Increased creatinine (usually transient) • Massive muscle necrosis • Prolonged strenuous exercise • Decreased creatinine • Severe loss of muscle mass • Small body size • Young age

  23. Relationship between BUN or creatinine and % functional nephrons is a “rectangular hyperbola” • Large changes in GFR “early” in renal disease cause small changes in BUN or creatinine • Small changes in GFR late in renal disesae cause big changes in BUN or serum creatinine

  24. Implication of azotemia • In a “steady state” and when non-renal factors have been eliminated from consideration, an increase of BUN or creatinine above normal implies that at least 75% of the nephrons are not functioning

  25. Magnitude of azotemia does NOT … • Differentiate pre-renal, renal, and post-renal processes • Differentiate acute from chronic processes • Differentiate reversible from irreversible processes • Differentiate progressive from non-progressive processes

  26. BUN vs serum creatinine • Both are relatively insensitive indicators of renal function (one is not more sensitive than the other) • Serum creatinine is affected by fewer non-renal variables • Creatinine is not affected by passive renal tubular reabsorption

  27. BUN/creatinine ratio • May be increased in pre-renal azotemia (e.g. dehydration) due to increased tubular reabsorption of urea at slower tubular flow rates • May be increased in post-renal azotemia caused by ruptured bladder due to easier reabsorption of urea across peritoneal membranes

  28. Localization of azotemia • Must consider: • History • Physical examination findings • Urine specific gravity before fluids or drugs that may interfere with concentrating ability • Patient’s response to fluid therapy

  29. Localization of azotemiaExample 1 • Hx: Persistent vomiting • PE: 10% dehydrated • Lab: BUN 70 mg/dL; USG 1.054 • Response to fluids: BUN 20 mg/dL • Conclusion: Pre-renal azotemia

  30. Localization of azotemiaExample 2 • Hx: Weight loss, lethargy, anorexia, vomiting • PE: 10% dehydrated • Lab: BUN 175 mg/dL; USG 1.013 • Response to fluids: BUN 75 mg/dL • Conclusion: Pre-renal and renal azotemia

  31. Localization of azotemiaExample 3 • Hx: Lethargy, vomiting • PE: 10% dehydrated • Lab: BUN 70 mg/dL; USG 1.013 • Response to fluids: BUN 20 mg/dL • Conclusion: Pre-renal azotemia, underlying renal disease

  32. Concept of clearance • Volume of plasma that would have to be filtered by the glomeruli in one minute to account for the amount of that substance appearing in the urine each minute under steady state conditions • Volume of plasma that contains the amount of the substance excreted in the urine in one minute under steady state conditions

  33. Clearance = UxV/Px • Where, • Ux = urine concentration of x (mg/dL) • Px = plasma concentration of x (mg/dL) • V = urine output (mL/min)

  34. Relationship of clearance to GFR • In a steady state, for a substance handled only be the kidneys that is neither reabsorbed nor secreted: • Amount filtered = amount excreted • GFR  Px = Ux  V • GFR = UxV/Px • Thus, the clearance of a substance that is neither reabsorbed nor secreted is equal to GFR

  35. Relationship of clearance to GFR • If X is neither reabsorbed nor secreted, clearance = GFR • If X is reabsorbed, clearance < GFR • If X is secreted, clearance > GFR

  36. Inulin clearance • Inulin is a polymer of fructose that meets all of the criteria for the ideal substance to measure GFR • Inulin clearance is the “gold standard” for GFR determination • Inulin must be continuously infused into the animal to achieve a steady state concentration in plasma

  37. Creatinine clearance • Creatinine is produced endogenously at a constant rate • It is not metabolized • It is excreted by the kidneys by glomerular filtration • It is neither reabsorbed nor secreted by the renal tubules • Creatinine clearance can be used to estimate GFR

  38. Endogenous creatinine clearance • Requirements: • Accurately timed collection of urine • Body weight • Serum and urine creatinine concentrations • Normal = 2 to 5 ml/min/kg • Underestimates GFR (compared to inulin clearance) due to non-creatinine chromagens in blood (Px increased)

  39. Exogenous creatinine clearance • Serum creatinine increased 10-fold by administration of creatinine • Minimizes effect of non-creatinine chromagens • More closely approximates inulin clearance • Technically more difficult than endogenous creatinine clearance

  40. Indications for creatinine clearance • Suspicion of renal disease in a non-aoztemic patient with PU/PD

  41. Sodium sulfanilate • Excreted solely by glomerular filtration • Plasma half-life is an indicator of GFR • Administered IV and heparinized blood samples collected at 30, 60 and 90 min • Normal values: 30-80 min (depending on species)

  42. Sodium sulfanilate • Advantage: Urine samples not required • Disadvantage: No numerical value for GFR is obtained Seldom used in clinical evaluation of renal function in domestic animals

  43. Radioisotopes • Used to determine glomerular filtration, renal plasma flow, and filtration fraction in domestic animals • Advantages • Do not require collection of urine • Not time consuming • Disadvantages • Use of radioactivity • Require special equipment and expertise

  44. Radioisotopes • Glomerular filtration rate • 125I-iothalamate • 51Cr-ethylenediaminetetraacetic acid (EDTA) • 99mTc-diethylenetriaminepentaacetic acid (DTPA) • Renal plasma flow • 131I-iodohippurate • 3H-tetraethylammonium bromide

More Related